Extended‐duration new oral anticoagulants for venous thromboprophylaxis in patients undergoing total hip arthroplasty: a meta‐analysis of the randomized controlled trials

Extended-duration thromboprophylaxis with low-molecular-weight heparin (LMWH) reduces the frequency of symptomatic venous thromboembolism (VTE) among patients undergoing total hip or knee arthroplasty 1. Recent trials have evaluated the efficacy and safety of the new oral anticoagulants (NOACs), dabigatran etexilate, rivaroxaban and apixaban, for VTE prevention in patients undergoing total hip arthroplasty (THA) 2-5. We performed a meta-analysis...